⬅ Back to All Recalls

DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP Recall Due to The chromatogr...

# Major Recall Alert: DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP Recalled Due to Out-of-Specification Chromatographic Purity Assay

Baxter has recently issued an important product recall of **DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP** due to a significant safety concern. Affected batches have been found to have an out-of-specification chromatographic purity assay, potentially jeopardizing patient safety.

Healthcare professionals and patients across Canada need to take immediate note of this recall in order to mitigate any potential risks. Here's everything you need to know about the issue, what steps to take, and how to stay updated on product recalls like this one.

## Why This Recall is Important

**DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP** is widely used in medical settings as a sedative or anesthetic for patients requiring intensive care or surgery. When the chromatographic purity assay in the product does not meet established specifications, there is an increased risk of administering a compromised treatment. Such quality control issues could lead to:
- Reduced efficacy of the drug
- Increased likelihood of adverse reactions during administration
- Potential complications during critical care treatments

Patient safety is paramount in the use of injectable medications, and deviations like this can put vulnerable individuals at risk.

Health Canada and Baxter have emphasized the importance of taking swift action to identify and mitigate potential harm caused by the affected lot.

## Details of the Recall

Here are the **key details** you need to know about the recall:
- **Brand Name**: Baxter
- **Product Name**: DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP
- **Issue Identified**: Chromatographic purity assay found to be out of specification in the affected lot
- **Recall Announced**: [Date 30587]
- **Distribution Area**: Canada
- **Reason for Concern**: Product quality not meeting established standards could lead to adverse effects during patient care

For more technical information, you can refer to the official Health Canada recall notice [here](https://recalls-rappels.canada.ca/en/alert-recall/dexmedetomidine-hydrochloride-injection-usp-out-specification-test-result).

## What You Should Do

If you are a healthcare professional, distributor, or patient, here are the proactive steps to take if you have this product in your possession:
1. **Stop Use Immediately**: Discontinue administration of any product from the affected lot.
2. **Check Inventory**: Inspect your supplies to identify and segregate recalled batches.
3. **Contact Baxter**: Reach out to the manufacturer for return instructions, batch identification, or further recall details.
4. **Consult a Healthcare Provider**: If you have recently received this product or suspect patient exposure, contact your doctor or medical team immediately. Monitor for potential side effects or adverse reactions.
5. **Report Adverse Events**: Any concerning incidents related to this medication can be reported to Health Canada through the MedEffect program.

## Stay Safe – Get Instant Recall Alerts

Product recalls like this underscore the importance of staying informed about medical and pharmaceutical product updates. Get instant alerts about critical recalls to protect yourself, your family, or your patients.

Download our free recall alert app today to:
- Receive real-time notifications about key recalls in Canada
- Quickly check for product safety updates
- Access detailed recall announcements with helpful resources

[**Download the Recall App Now**]

## Final Thoughts

With patient safety on the line, Baxter’s recall of **DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP** serves as a critical reminder to consistently check the quality and assurance of medical products in circulation. Stay vigilant, informed, and proactive about recalls to ensure the health and well-being of those who depend on these treatments.

For the latest updates, follow Health Canada’s official recall announcement [here](https://recalls-rappels.canada.ca/en/alert-recall/dexmedetomidine-hydrochloride-injection-usp-out-specification-test-result).

Stay safe and informed!

⬅ Back to All Recalls